	Association between the Prognostic Nutritional Index and survival outcomes in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. Transl Cancer Res Qian J, Gao S, Zhu Y, Wu J. PMID: 42445439 [PubMed]
	Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial. Gland Surg Bethel F, Corona A, Hosein P, Datta J. PMID: 42445089 [PubMed]
	Case Report: A four-stage diagnostic cascade: from coronary stents to pancreatic cancer in a patient with recurrent chest pain. Front Oncol Lin T, Huang Z, Huang X. PMID: 42444795 [PubMed]
	Management of cancer-associated thrombosis in patients with gastrointestinal cancers: lights and shadows. Cancer Treat Rev Gervaso L, Cioli E, Rosanu NM, Cella CA, Khorana AA, Fazio N. PMID: 42443040 [PubMed - as supplied by publisher]
	Implications and risk of new versus persisting intraductal papillary mucinous neoplasms after pancreatic surgery: meta-analysis. BJS Open van Bodegraven AJ, Marstaller-Walz KM, Padoan V, Heo D, Perri G, Burchell GL, Loos M, Michalski CW, Besselink MG, Cillo U, Rompen IF, Marchegiani G. PMID: 42441942 [PubMed - indexed for MEDLINE]
	Baseline and dynamic neutrophil-to-lymphocyte ratio predicts overall survival in unresectable pancreatic cancer following dose-escalated SBRT: a ten-year longitudinal study. Front Mol Biosci Di Y, Sun Z, Song Z, Meng L. PMID: 42440477 [PubMed]
	Perioperative immune checkpoint inhibitors with or without chemotherapy versus placebo with or without chemotherapy in elderly people with localised non-small cell lung cancer. Cochrane Database Syst Rev Plissonneau E, Marchal C, Malouf R, Calais F, Westeel V, Orillard E. PMID: 42440312 [PubMed - indexed for MEDLINE]
	Primary pancreatic paraganglioma: a systematic review. Endocrine Guerrero-Pérez F, Sánchez-Barrera R, Quiñonero Góngora P, Serrano T, Busquets J, Secanella L, Vercher-Conejero JL, Iglesias P. PMID: 42440163 [PubMed - indexed for MEDLINE]
	Preoperative predictors of early recurrence after neoadjuvant gemcitabine plus S-1 in resectable pancreatic cancer: a multicenter study. Surg Today Shirai Y, Hamura R, Tsunematsu M, Gocho T, Sakamoto T, Onda S, Tanji Y, Okui N, Matsumoto M, Furukawa K, Haruki K, Ikegami T. PMID: 42439926 [PubMed - as supplied by publisher]
	Surveillance for Pancreatic Cancer: Knowledge, Motivations, Barriers, and Preferences Among High-Risk Individuals and Underserved Populations. Cancer Control Houweling EV, McCoy S, Sheppard B, Guimaraes AR, Sears R, Shannon J, Farris PE, Jäderholm CM, Coté GA. PMID: 42439864 [PubMed - indexed for MEDLINE]
	Etiology-Driven Mouse Models of Hepatocellular Carcinoma: Paving the Way for Precision Oncology. J Hepatocell Carcinoma Cao W, Fan Y, Chen H, Sun J, Jin X. PMID: 42438783 [PubMed]
	Neoantigens in Cancer Immunotherapy: An Overview with a Focus on Non-small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma. Iran J Allergy Asthma Immunol Eskandari-Malayeri F, Shekarchian S, Mortaz E. PMID: 42437308 [PubMed - indexed for MEDLINE]
	Assessing collagenase-a and type-II mediated degradation of human type-I collagen by photoacoustic spectroscopy toward clinical translation in cancer progression. Sci Rep Biswas S, Chandra S, Bhat G, Mathew S, Murali TS, Mahato KK. PMID: 42436335 [PubMed - as supplied by publisher]
	Hydrogel-based platforms for localized cancer treatment: Design strategies for precision therapeutic delivery. J Control Release Salathia S, Casadidio C, Censi R. PMID: 42435859 [PubMed - as supplied by publisher]
	Periodic surveillance of intraductal papillary mucinous neoplasms: gaps in evidence and future directions. J Natl Cancer Inst Hamada T, Oyama H, Nakai Y, Petrov MS. PMID: 42435394 [PubMed - as supplied by publisher]
	Prognostic value of lactate dehydrogenase-to-albumin ratio in metastatic/recurrent pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel: a single-center retrospective cohort study. J Gastrointest Oncol Yamauchi Y, Sofuni A, Nagakawa Y, Itoi T. PMID: 42434227 [PubMed]
	From pancreatic ductal adenocarcinoma to non-small cell lung cancer: daraxonrasib in the RASolute 302 trial - a pan-RAS(ON) breakthrough or the next evolution in targeting diverse oncogenic RAS variants? Ann Med Surg (Lond) Qaseem M, Ali MS, Ali S, Hasan AH. PMID: 42433811 [PubMed]
	Dietary fatty acid intake and the risk of pancreatic cancer: a dose-response meta-analysis of observational studies. Ann Med Surg (Lond) Al Masri MK, Hasan MK, Ali SA, Alsubaiei AA, Ali SA, AlMaazmi AM, Saleh SAK, Adly HM, Kutbi E, AlJurayyan AN, Abu-Zaid A. PMID: 42433782 [PubMed]
	Real-World Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE007): A Multicenter Retrospective Study. Liver Cancer Ye L, Liu GX, Yang DL, Zeng FJ, Liu J, Yao HB, Nong JL, Liu SP, Peng N, Li WF, Wu PS, Qin C, Su Z, Ou JJ, Dong XF, Yan YH, Zhong TM, Wu MS, Chen YZ, Wang GD, Li MJ, Wang XY, Yang FQ, Chen SC, Yang YY, Chen K, Lai YC, Pang QQ, Liang XM, Mao XS, Liang YR, Li FX, Shi H, Li RJ, Xiang BD, Ma L, Zhong JH, Yu YQ, GUIDANCE investigators. PMID: 42433265 [PubMed - as supplied by publisher]
	Impact of Stent Type on Surgical Outcomes in Pancreatic Cancer Patients Undergoing Preoperative Biliary Drainage. Dig Endosc Tamura T, Matsumori T, Nishikawa Y, Kitagawa K, Nagai M, Shimizu A, Matsumoto I, Masuda A, Sakai A, Yamai T, Tomokuni A, Ikeura T, Ito T, Doi T, Miyake H, Maruyama H, Ishikawa-Kakiya Y, Ogura T, Ueno S, Shiomi H, Tsujimoto A, Shintani S, Ikeda T, Uenoyama Y, Emori T, Shimatani M, Hanada K, Kitano M, Takenaka M. PMID: 42433174 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 60827

Page 1 of 3042



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy